Skip to main content

Articles

Page 268 of 337

  1. Genetic variants in inflammation-related genes have been associated with biliary stones and biliary tract cancers in previous studies.

    Authors: Felipe A Castro, Jill Koshiol, Ann W Hsing, Yu-Tang Gao, Asif Rashid, Lisa W Chu, Ming-Chang Shen, Bing-Shen Wang, Tian-Qua Han, Bai-He Zhang, Shelley Niwa, Kai Yu, Hong Zhang, Stephen Chanock and Gabriella Andreotti
    Citation: BMC Cancer 2012 12:468
  2. MTHFR 677C>T polymorphism is a genetic alteration in an enzyme involved in folate metabolism, but its effect on host susceptibility to cervical cancer is still uncertain. The aim of this study was to investiga...

    Authors: Qiang Mei, Daijun Zhou, Jinyu Gao, Shu Shen, Jinlin Wu, Linna Guo and Zhiqing Liang
    Citation: BMC Cancer 2012 12:467
  3. Cholangiocarcinoma (CC) is a primary liver cancer with increasing incidence worldwide. Despite all efforts made in past years, prognosis remains to be poor. At least in part, this might be explained by a prono...

    Authors: Thorsten Lieke, Wolf Ramackers, Sabine Bergmann, Jürgen Klempnauer, Michael Winkler and Johannes Klose
    Citation: BMC Cancer 2012 12:466
  4. Because of the infrequence of salivary gland tumours and their complex histopathological diagnosis it is still difficult to exactly predict their clinical course by means of recurrence, malignant progression a...

    Authors: Jochen Winter, Annette Pantelis, Dominik Kraus, Jan Reckenbeil, Rudolf Reich, Soeren Jepsen, Hans-Peter Fischer, Jean-Pierre Allam, Natalija Novak and Matthias Wenghoefer
    Citation: BMC Cancer 2012 12:465
  5. Secreted protein acidic and rich in cysteine (SPARC), a calcium-binding matricellular glycoprotein, is implicated in the progressions of some cancers. However, no information has been available to date regardi...

    Authors: Jie Chen, Dehuan Shi, Xiaoyan Liu, Shuang Fang, Jie Zhang and Yueran Zhao
    Citation: BMC Cancer 2012 12:464
  6. Only a minority of cancer patients benefits from the combination of EGFR-inhibition and radiotherapy in head and neck squamous cell carcinoma (HNSCC). A potential resistance mechanism is activation of EGFR and...

    Authors: Hanneke Stegeman, Johannes H Kaanders, Deric L Wheeler, Albert J van der Kogel, Marieke M Verheijen, Stijn J Waaijer, Mari Iida, Reidar Grénman, Paul N Span and Johan Bussink
    Citation: BMC Cancer 2012 12:463
  7. Advanced ovarian cancer is characterized by peritoneal metastasis and the accumulation of ascites. Peritoneal metastasis of ovarian cancer is a major cause of the negative treatment outcome, as these metastase...

    Authors: Hiroaki Konishi, Akimitsu Takagi, Akinobu Kurita, Norimasa Kaneda and Takeshi Matsuzaki
    Citation: BMC Cancer 2012 12:462
  8. The polycomb group (PcG) family BMI1, acting downstream of the hedgehog (Hh) pathway, plays an essential role in the self-renewal of haematopoietic, neural, and intestinal stem cells, and is dysregulated in ma...

    Authors: Reigetsu Yoshikawa, Tohru Tsujimura, Lihua Tao, Norihiko Kamikonya and Yoshinori Fujiwara
    Citation: BMC Cancer 2012 12:461
  9. Treatment of patients with stage pT1 urothelial bladder cancer (UBC) continues to be a challenge due to its unpredictable clinical course. Reliable molecular markers that help to determine appropriate individu...

    Authors: Wolfgang Otto, Peter C Rubenwolf, Maximilian Burger, Hans-Martin Fritsche, Wolfgang Rößler, Matthias May, Arndt Hartmann, Ferdinand Hofstädter, Wolf F Wieland and Stefan Denzinger
    Citation: BMC Cancer 2012 12:459
  10. Acquired resistance to endocrine therapy in breast cancer is a significant problem with relapse being associated with local and/or regional recurrence and frequent distant metastases. Breast cancer cell models...

    Authors: Stephen Hiscox, Bedanta Baruah, Chris Smith, Rebecca Bellerby, Lindy Goddard, Nicola Jordan, Zaruhi Poghosyan, Robert I Nicholson, Peter Barrett-Lee and Julia Gee
    Citation: BMC Cancer 2012 12:458
  11. The TNFAIP3 gene, which encodes a ubiquitin-modifying enzyme (A20) involved in the negative regulation of NF-κB signaling, is frequently inactivated by gene deletions/mutations in a variety of B-cell malignancies...

    Authors: Junko Nomoto, Nobuhiro Hiramoto, Motohiro Kato, Masashi Sanada, Akiko Miyagi Maeshima, Hirokazu Taniguchi, Fumie Hosoda, Yoshitaka Asakura, Wataru Munakata, Naohiro Sekiguchi, Dai Maruyama, Takashi Watanabe, Hitoshi Nakagama, Kengo Takeuchi, Kensei Tobinai, Seishi Ogawa…
    Citation: BMC Cancer 2012 12:457
  12. EndoPredict (EP) is a clinically validated multianalyte gene expression test to predict distant metastasis in ER-positive, HER2-negative breast cancer treated with endocrine therapy alone. The test is based on...

    Authors: Ralf Kronenwett, Kerstin Bohmann, Judith Prinzler, Bruno V Sinn, Franziska Haufe, Claudia Roth, Manuela Averdick, Tanja Ropers, Claudia Windbergs, Jan C Brase, Karsten E Weber, Karin Fisch, Berit M Müller, Marcus Schmidt, Martin Filipits, Peter Dubsky…
    Citation: BMC Cancer 2012 12:456
  13. Patients with metastatic melanoma have a poor median rate of survival. It is therefore necessary to increase our knowledge about melanoma cell dissemination which includes extravasation, where cancer cells cro...

    Authors: Stephanie Ghislin, Dorian Obino, Sandrine Middendorp, Nicole Boggetto, Catherine Alcaide-Loridan and Frederique Deshayes
    Citation: BMC Cancer 2012 12:455
  14. While BRCA mutation carriers possess a 20-40% lifetime risk of developing ovarian cancer, knowledge about genetic modifying factors influencing the phenotypic expression remains obscure. We explored the distribut...

    Authors: Merete Bjørnslett, Stian Knappskog, Per Eystein Lønning and Anne Dørum
    Citation: BMC Cancer 2012 12:454
  15. There has been limited study on the effect of infection with different hepatitis C virus (HCV) genotypes on the risk of hepatocellular carcinoma (HCC) in hepatitis B virus (HBV) endemic regions of Asia.

    Authors: Jin-Kyoung Oh, Hai-Rim Shin, Min Kyung Lim, Heeyoun Cho, Dong-Il Kim, Youngmee Jee, Haesun Yun and Keun-Young Yoo
    Citation: BMC Cancer 2012 12:452
  16. Despite strong efforts to improve clinical outcome of ovarian cancer patients by conventional and targeted immuno-based therapies, the prognosis of advanced ovarian cancer is still poor. Natural killer (NK) ce...

    Authors: Nina Gottschalk, Stephan Lang, Rainer Kimmig, Mahavir Singh and Sven Brandau
    Citation: BMC Cancer 2012 12:451
  17. One-third of breast cancers display amplifications of the ERBB2 gene encoding the HER2 kinase receptor. Trastuzumab, a humanized antibody directed against an epitope on subdomain IV of the extracellular domain of...

    Authors: Ceyhan Ceran, Murat Cokol, Sultan Cingoz, Ipek Tasan, Mehmet Ozturk and Tamer Yagci
    Citation: BMC Cancer 2012 12:450
  18. In non-small cell lung cancer (NSCLC), interstitial hypertension is a barrier to chemotherapy delivery, and is mediated by platelet derived growth factor receptor (PDGFR). Antagonizing PDGFR with imatinib may ...

    Authors: Julie E Bauman, Keith D Eaton, Sarah G Wallace, Laurie L Carr, Sang-Joon Lee, Dennie V Jones, Hugo Arias-Pulido, Lisa A Cerilli and Renato G Martins
    Citation: BMC Cancer 2012 12:449
  19. Chemotherapeutic bioassay for colorectal cancer (CRC) with a rat model bearing chemically-induced CRCs plays an important role in the development of new anti-tumor drugs and regimens. Although several protocol...

    Authors: Kazuto Yoshimi, Takao Hashimoto, Yusuke Niwa, Kazuya Hata, Tadao Serikawa, Takuji Tanaka and Takashi Kuramoto
    Citation: BMC Cancer 2012 12:448
  20. A 21-gene recurrence score (RS) assay may inform adjuvant systematic treatment decisions in women with early stage breast cancer. We sought to investigate the cost effectiveness of using the RS-assay versus cu...

    Authors: Malek B Hannouf, Bin Xie, Muriel Brackstone and Gregory S Zaric
    Citation: BMC Cancer 2012 12:447
  21. Research on physical activity and nutrition interventions aimed at positively impacting symptom management, treatment-related recovery and quality of life has largely excluded head and neck (HN) cancer populat...

    Authors: Lauren C Capozzi, Harold Lau, Raylene A Reimer, Margaret McNeely, Janine Giese-Davis and S Nicole Culos-Reed
    Citation: BMC Cancer 2012 12:446
  22. Breast cancer and its metastatic progression is mainly directed by epithelial to mesenchymal transition (EMT), a phenomenon supported by specific transcription factors and miRNAs.

    Authors: Elisabetta Lambertini, Andrea Lolli, Federica Vezzali, Letizia Penolazzi, Roberto Gambari and Roberta Piva
    Citation: BMC Cancer 2012 12:445
  23. Li-Fraumeni syndrome (LFS) is a hereditary cancer predisposition syndrome that is commonly associated with a germline mutation in the tumor suppressor gene p53. Loss of p53 results in increased expression of CD44...

    Authors: Go J Yoshida, Yasushi Fuchimoto, Tomoo Osumi, Hiroyuki Shimada, Seiichi Hosaka, Hideo Morioka, Makio Mukai, Yohei Masugi, Michiie Sakamoto and Tatsuo Kuroda
    Citation: BMC Cancer 2012 12:444
  24. The aging of the Italian population will unavoidably lead to a growing number of persons diagnosed and living with cancer. A comprehensive description of the burden of cancer mortality among Italian elderly (6...

    Authors: Ettore Bidoli, Lucia Fratino, Silvia Bruzzone, Marilena Pappagallo, Paolo De Paoli, Umberto Tirelli and Diego Serraino
    Citation: BMC Cancer 2012 12:443
  25. Cyclophilin A (CypA) is a cytosolic protein possessing peptidyl-prolyl isomerase activity that was recently reported to be overexpressed in several cancers. Here, we explored the biology and molecular mechanis...

    Authors: Zhe Qian, Xiaoting Zhao, Mei Jiang, Wenyun Jia, Chunyan Zhang, Yue Wang, Baolan Li and Wentao Yue
    Citation: BMC Cancer 2012 12:442
  26. Very few studies examine the longitudinal prevalence of problems and the awareness or use of clinical programs by patients who report these problems. Of the studies that examine age, gender and marital status ...

    Authors: Janine Giese-Davis, Amy Waller, Linda E Carlson, Shannon Groff, Lihong Zhong, Eric Neri, Sacha M Bachor, Jassandre Adamyk-Simpson, Kate MS Rancourt, Bernie Dunlop and Barry D Bultz
    Citation: BMC Cancer 2012 12:441
  27. To reduce mortality, women with a family history of breast cancer often start mammography screening at a younger age than the general population. Breast density is high in over 50% of women younger than 50 yea...

    Authors: Sepideh Saadatmand, Emiel J T Rutgers, RobAEM Tollenaar, Hermien M Zonderland, MargreetGEM Ausems, KristienBMI Keymeulen, Margreet S Schlooz-Vries, Linetta B Koppert, Eveline A M Heijnsdijk, Caroline Seynaeve, Cees Verhoef, Jan C Oosterwijk, Inge-Marie Obdeijn, Harry J de Koning and Madeleine M A Tilanus-Linthorst
    Citation: BMC Cancer 2012 12:440
  28. Postoperative interferon-α(IFN-α) treatment delays hepatocellular carcinoma(HCC) recurrence and prolongs patient survival, and may thus be an effective form of adjuvant therapy. However, clinical observations ...

    Authors: Ju-Bo Zhang, Hui-Chuan Sun, Wei-Dong Jia, Peng-Yuan Zhuang, Yong-Bing Qian, Xiao-Dong Zhu, Ling-Qun Kong, Lu Wang, Wei-Zhong Wu and Zhao-You Tang
    Citation: BMC Cancer 2012 12:439
  29. Integument-related toxicities are common during epidermal growth factor receptor (EGFR)-targeted therapy. Panitumumab is a fully human monoclonal antibody targeting the EGFR that significantly improves progres...

    Authors: Josef Thaler, Meinolf Karthaus, Laurent Mineur, Richard Greil, Henry Letocha, Ralf Hofheinz, Eva Fernebro, Erick Gamelin, Ana Baños and Claus-Henning Köhne
    Citation: BMC Cancer 2012 12:438
  30. Our recent studies suggested that the chromodomain helicase DNA binding protein 1-like (CHD1L) gene plays an oncogenic role in human hepatocellular carcinoma. However, the status of CHD1L protein expression in ov...

    Authors: Wei-Peng He, Juan Zhou, Mu-Yan Cai, Xiang-Shen Xiao, Yi-Ji Liao, Hsiang-Fu Kung, Xin-Yuan Guan, Dan Xie and Guo-Fen Yang
    Citation: BMC Cancer 2012 12:437
  31. DNA interstrand cross-links (ICLs) are critical lesions produced by several cancer chemotherapy agents including platinum drugs and nitrogen mustards. We have previously shown in haematological (multiple myelo...

    Authors: Victoria J Spanswick, Helen L Lowe, Claire Newton, John P Bingham, Alessia Bagnobianchi, Konstantinos Kiakos, Charles Craddock, Jonathan A Ledermann, Daniel Hochhauser and John A Hartley
    Citation: BMC Cancer 2012 12:436
  32. Data that directly associate utilization of novel systemic therapies with survival trends in metastatic breast cancer (MBC) are limited. In the setting of de novo MBC, large registry analyses cite positive tempor...

    Authors: Sumanta K Pal, Mary Dehaven, Rebecca A Nelson, Susan Onami, JoAnn Hsu, Sarah Waliany, Laura Kruper and Joanne Mortimer
    Citation: BMC Cancer 2012 12:435
  33. Nucleoside analogs used in the chemotherapy of solid tumors, such as the capecitabine catabolite 5-deoxy-5-fluorouridine (5-DFUR) trigger a transcriptomic response that involves the aquaglyceroporin aquaporin 3...

    Authors: Laia Trigueros-Motos, Sandra Pérez-Torras, F Javier Casado, Míriam Molina-Arcas and Marçal Pastor-Anglada
    Citation: BMC Cancer 2012 12:434
  34. Metabolic genes have been associated with the function of metabolizing and detoxifying environmental carcinogens. Polymorphisms present in these genes could lead to changes in their metabolizing and detoxifyin...

    Authors: M Felicitas López-Cima, Sara M Álvarez-Avellón, Teresa Pascual, Ana Fernández-Somoano and Adonina Tardón
    Citation: BMC Cancer 2012 12:433
  35. There has been substantial increase in use of androgen deprivation therapy as adjuvant management of prostate cancer. However, this leads to a range of musculoskeletal toxicities including reduced bone mass an...

    Authors: Robert U Newton, Dennis R Taaffe, Nigel Spry, Prue Cormie, Suzanne K Chambers, Robert A Gardiner, David HK Shum, David Joseph and Daniel A Galvão
    Citation: BMC Cancer 2012 12:432
  36. The CD34+CD38- subset of AML cells is enriched for resistance to current chemotherapeutic agents and considered to contribute to disease progression and relapse in Acute Myeloid Leukaemia (AML) patients following...

    Authors: Mays Jawad, Ning Yu, Claire Seedhouse, Karuna Tandon, Nigel H Russell and Monica Pallis
    Citation: BMC Cancer 2012 12:431
  37. The survival of unresectable pancreatic cancer patients is extremely poor. The aim of this study was to examine if tumor size could predict survival length in order to optimize patient care.

    Authors: Henrik Forssell, Katrin Pröh, Michael Wester and Hans Krona
    Citation: BMC Cancer 2012 12:429
  38. The diagnosis of malignant pleural effusions (MPE) is often clinically challenging, especially if the cytology is negative for malignancy. DNA integrity index has been reported to be a marker of malignancy. Th...

    Authors: Krishna B Sriram, Vandana Relan, Belinda E Clarke, Edwina E Duhig, Morgan N Windsor, Kevin S Matar, Rishendran Naidoo, Linda Passmore, Elizabeth McCaul, Deborah Courtney, Ian A Yang, Rayleen V Bowman and Kwun M Fong
    Citation: BMC Cancer 2012 12:428
  39. Hepatoblastoma (HB) is the most common primary, malignant pediatric liver tumor in children. The treatment results for affected children have markedly improved in recent decades. However, the prognosis for hig...

    Authors: Shu-Cheng Zhang, Wei-Lin Wang, Wei-Song Cai, Kai-Lei Jiang and Zheng-Wei Yuan
    Citation: BMC Cancer 2012 12:427
  40. We previously observed that a radiotherapy-induced biochemical response in plasma was associated with favourable outcome in head and neck squamous carcinoma cancer (HNSCC) patients. The aim of the present stud...

    Authors: Siv K Bøhn, Kjell M Russnes, Amrit K Sakhi, Magne Thoresen, Marit Holden, JanØ Moskaug, Mari C Myhrstad, Ole K Olstad, Sigbjørn Smeland and Rune Blomhoff
    Citation: BMC Cancer 2012 12:426
  41. Maintenance therapy for non-small cell lung cancer (NSCLC) aims to extend disease control after first-line chemotherapy with active and well-tolerated agents. The utility of continuation maintenance therapy re...

    Authors: Nabil Mubarak, Rabab Gaafar, Samir Shehata, Tarek Hashem, Dani Abigeres, Hamdy A Azim, Gamal El-Husseiny, Hamed Al-Husaini and Zhixin Liu
    Citation: BMC Cancer 2012 12:423
  42. Taxane is one of the first line treatments of lung cancer. In order to identify novel single nucleotide polymorphisms (SNPs) that might contribute to taxane response, we performed a genome-wide association stu...

    Authors: Nifang Niu, Daniel J Schaid, Ryan P Abo, Krishna Kalari, Brooke L Fridley, Qiping Feng, Gregory Jenkins, Anthony Batzler, Abra G Brisbin, Julie M Cunningham, Liang Li, Zhifu Sun, Ping Yang and Liewei Wang
    Citation: BMC Cancer 2012 12:422
  43. Exosomes are nanovesicles secreted by tumour cells which have roles in paracrine signalling during tumour progression, including tumour-stromal interactions, activation of proliferative pathways and bestowing ...

    Authors: Hamish W King, Michael Z Michael and Jonathan M Gleadle
    Citation: BMC Cancer 2012 12:421
  44. Recently, S-1, a novel 5-fluorouracil (5-FU)-based agent containing the strong dihydropyrimidine dehydrogenase (DPD) inhibitor, 5-chloro-2,4-dihydropyrimidine (CDHP) has been clinically used to treat various n...

    Authors: Hiroki Ide, Eiji Kikuchi, Masanori Hasegawa, Norihide Kozakai, Takeo Kosaka, Akira Miyajima and Mototsugu Oya
    Citation: BMC Cancer 2012 12:420
  45. Pancreatic cancer remains the deadliest of all cancers, with a mortality rate of 91%. Gemcitabine is considered the gold chemotherapeutic standard, but only marginally improves life-span due to its chemical in...

    Authors: Anne-Laure Papa, Sudipta Basu, Poulomi Sengupta, Deboshri Banerjee, Shiladitya Sengupta and Rania Harfouche
    Citation: BMC Cancer 2012 12:419

Featured videos

View featured videos from across the BMC-series journals